May 17, 2017 / 1:11 PM / 6 months ago

BRIEF-Zealand Q1 net loss DKK 26.3 million

May 17 (Reuters) - ZEALAND PHARMA A/S

* REG-ZEALAND REPORTS RESULTS FOR THE FIRST THREE MONTHS OF 2017 (UNAUDITED)

* Q1 REVENUE OF DKK 77.6 MILLION (6.7 MILLION IN Q1 2016), INCLUDING MILESTONE REVENUE OF DKK 69.6 MILLION

* Q1 NET LOSS DKK 26.3 MILLION VERSUS LOSS DKK 77.8 MILLION YEAR AGO

* SAYS PHASE 2 TRIAL INVESTIGATING GLEPAGLUTIDE FOR THE TREATMENT OF SHORT BOWEL SYNDROME COMPLETED. RESULTS ARE EXPECTED BY END JUNE 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below